Related Experiment Video

Updated: Jul 7, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

[Pediatrics]

S Fanconi1, O Reinberg, C Gapany

  • 1Départment médico-chirurgical de pédiatrie, Service de pédiatrie, CHUV, 1011 Lausanne. sergio.fanconi@chuv.ch

Revue Medicale Suisse
|February 7, 2008
PubMed

Insights

Surgical intervention for cryptorchidism at 12 months is recommended over hormonal treatment to preserve fertility and prevent testicular tumors. Shorter antibiotic courses are effective for streptococcal pharyngitis, while new heart failure treatments and early corticosteroid use in Duchenne muscular dystrophy show promise.

Area of Science:

  • Pediatrics
  • Cardiology
  • Endocrinology

Context:

  • This article reviews recent advancements in managing common and rare pediatric and adult diseases.
  • It highlights updated treatment protocols and emerging therapies across various medical disciplines.

Purpose:

  • To provide a concise overview of key medical progress in four distinct conditions: cryptorchidism, streptococcal pharyngitis, cardiac failure, and Duchenne muscular dystrophy.
  • To inform clinicians about evidence-based updates for improved patient outcomes.

Summary:

  • Optimal management for cryptorchidism involves surgery around 12 months, avoiding hormonal therapy to protect fertility and reduce tumor risk.
  • Oral cephalosporins offer a shorter, effective alternative to 10-day penicillin courses for streptococcal pharyngitis.
  • Newer agents like carvedilol, levosimendan, and nesiritide represent a novel hormonal approach to managing cardiac failure.
  • Early initiation of corticosteroids, coupled with a multidisciplinary strategy, enhances quality of life and survival in Duchenne muscular dystrophy.

Impact:

  • These updates aim to refine clinical practice, leading to better management of these conditions.
  • The discussed advancements offer improved therapeutic options, potentially enhancing patient prognosis and well-being.
  • This review underscores the importance of timely and appropriate medical interventions for diverse pathologies.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...